Taking a complexity perspective.
The first paper in this series 17 outlines aspects of complexity associated with complex interventions and health systems that can potentially be explored by different types of evidence, including synthesis of quantitative and qualitative evidence. Petticrew et al 17 distinguish between a complex interventions perspective and a complex systems perspective. A complex interventions perspective defines interventions as having “implicit conceptual boundaries, representing a flexible, but common set of practices, often linked by an explicit or implicit theory about how they work”. A complex systems perspective differs in that “ complexity arises from the relationships and interactions between a system’s agents (eg, people, or groups that interact with each other and their environment), and its context. A system perspective conceives the intervention as being part of the system, and emphasises changes and interconnections within the system itself”. Aspects of complexity associated with implementation of complex interventions in health systems that could potentially be addressed with a synthesis of quantitative and qualitative evidence are summarised in table 2 . Another paper in the series outlines criteria used in a new evidence to decision framework for making decisions about complex interventions implemented in complex systems, against which the need for quantitative and qualitative evidence can be mapped. 16 A further paper 18 that explores how context is dealt with in guidelines and reviews taking a complexity perspective also recommends using both quantitative and qualitative evidence to better understand context as a source of complexity. Mixed-method syntheses of quantitative and qualitative evidence can also help with understanding of whether there has been theory failure and or implementation failure. The Cochrane Qualitative and Implementation Methods Group provide additional guidance on exploring implementation and theory failure that can be adapted to address aspects of complexity of complex interventions when implemented in health systems. 19
Health-system complexity-related questions that a synthesis of quantitative and qualitative evidence could address (derived from Petticrew et al 17 )
Aspect of complexity of interest | Examples of potential research question(s) that a synthesis of qualitative and quantitative evidence could address | Types of studies or data that could contribute to a review of qualitative and quantitative evidence |
What ‘is’ the system? How can it be described? | What are the main influences on the health problem? How are they created and maintained? How do these influences interconnect? Where might one intervene in the system? | Quantitative: previous systematic reviews of the causes of the problem); epidemiological studies (eg, cohort studies examining risk factors of obesity); network analysis studies showing the nature of social and other systems Qualitative data: theoretical papers; policy documents |
Interactions of interventions with context and adaptation | Qualitative: (1) eg, qualitative studies; case studies Quantitative: (2) trials or other effectiveness studies from different contexts; multicentre trials, with stratified reporting of findings; other quantitative studies that provide evidence of moderating effects of context | |
System adaptivity (how does the system change?) | (How) does the system change when the intervention is introduced? Which aspects of the system are affected? Does this potentiate or dampen its effects? | Quantitative: longitudinal data; possibly historical data; effectiveness studies providing evidence of differential effects across different contexts; system modelling (eg, agent-based modelling) Qualitative: qualitative studies; case studies |
Emergent properties | What are the effects (anticipated and unanticipated) which follow from this system change? | Quantitative: prospective quantitative evaluations; retrospective studies (eg, case–control studies, surveys) may also help identify less common effects; dose–response evaluations of impacts at aggregate level in individual studies or across studies included with systematic reviews (see suggested examples) Qualitative: qualitative studies |
Positive (reinforcing) and negative (balancing) feedback loops | What explains change in the effectiveness of the intervention over time? Are the effects of an intervention are damped/suppressed by other aspects of the system (eg, contextual influences?) | Quantitative: studies of moderators of effectiveness; long-term longitudinal studies Qualitative: studies of factors that enable or inhibit implementation of interventions |
Multiple (health and non-health) outcomes | What changes in processes and outcomes follow the introduction of this system change? At what levels in the system are they experienced? | Quantitative: studies tracking change in the system over time Qualitative: studies exploring effects of the change in individuals, families, communities (including equity considerations and factors that affect engagement and participation in change) |
It may not be apparent which aspects of complexity or which elements of the complex intervention or health system can be explored in a guideline process, or whether combining qualitative and quantitative evidence in a mixed-method synthesis will be useful, until the available evidence is scoped and mapped. 17 20 A more extensive lead in phase is typically required to scope the available evidence, engage with stakeholders and to refine the review parameters and questions that can then be mapped against potential review designs and methods of synthesis. 20 At the scoping stage, it is also common to decide on a theoretical perspective 21 or undertake further work to refine a theoretical perspective. 22 This is also the stage to begin articulating the programme theory of the complex intervention that may be further developed to refine an understanding of complexity and show how the intervention is implemented in and impacts on the wider health system. 17 23 24 In practice, this process can be lengthy, iterative and fluid with multiple revisions to the review scope, often developing and adapting a logic model 17 as the available evidence becomes known and the potential to incorporate different types of review designs and syntheses of quantitative and qualitative evidence becomes better understood. 25 Further questions, propositions or hypotheses may emerge as the reviews progress and therefore the protocols generally need to be developed iteratively over time rather than a priori.
Following a scoping exercise and definition of key questions, the next step in the guideline development process is to identify existing or commission new systematic reviews to locate and summarise the best available evidence in relation to each question. For example, case study 2, ‘Optimising health worker roles for maternal and newborn health through task shifting’, included quantitative reviews that did and did not take an additional complexity perspective, and qualitative evidence syntheses that were able to explain how specific elements of complexity impacted on intervention outcomes within the wider health system. Further understanding of health system complexity was facilitated through the conduct of additional country-level case studies that contributed to an overall understanding of what worked and what happened when lay health worker interventions were implemented. See table 1 online supplementary file 2 .
There are a few existing examples, which we draw on in this paper, but integrating quantitative and qualitative evidence in a mixed-method synthesis is relatively uncommon in a guideline process. Box 2 includes a set of key questions that guideline developers and review authors contemplating combining quantitative and qualitative evidence in mixed-methods design might ask. Subsequent sections provide more information and signposting to further reading to help address these key questions.
Compound questions requiring both quantitative and qualitative evidence?
Questions requiring mixed-methods studies?
Separate quantitative and qualitative questions?
Separate quantitative and qualitative research studies?
Related quantitative and qualitative research studies?
Mixed-methods studies?
Quantitative unpublished data and/or qualitative unpublished data, eg, narrative survey data?
Throughout the review?
Following separate reviews?
At the question point?
At the synthesis point?
At the evidence to recommendations stage?
Or a combination?
Narrative synthesis or summary?
Quantitising approach, eg, frequency analysis?
Qualitising approach, eg, thematic synthesis?
Tabulation?
Logic model?
Conceptual model/framework?
Graphical approach?
Petticrew et al 17 define the different aspects of complexity and examples of complexity-related questions that can potentially be explored in guidelines and systematic reviews taking a complexity perspective. Relevant aspects of complexity outlined by Petticrew et al 17 are summarised in table 2 below, together with the corresponding questions that could be addressed in a synthesis combining qualitative and quantitative evidence. Importantly, the aspects of complexity and their associated concepts of interest have however yet to be translated fully in primary health research or systematic reviews. There are few known examples where selected complexity concepts have been used to analyse or reanalyse a primary intervention study. Most notable is Chandler et al 26 who specifically set out to identify and translate a set of relevant complexity theory concepts for application in health systems research. Chandler then reanalysed a trial process evaluation using selected complexity theory concepts to better understand the complex causal pathway in the health system that explains some aspects of complexity in table 2 .
Rehfeuss et al 16 also recommends upfront consideration of the WHO-INTEGRATE evidence to decision criteria when planning a guideline and formulating questions. The criteria reflect WHO norms and values and take account of a complexity perspective. The framework can be used by guideline development groups as a menu to decide which criteria to prioritise, and which study types and synthesis methods can be used to collect evidence for each criterion. Many of the criteria and their related questions can be addressed using a synthesis of quantitative and qualitative evidence: the balance of benefits and harms, human rights and sociocultural acceptability, health equity, societal implications and feasibility (see table 3 ). Similar aspects in the DECIDE framework 15 could also be addressed using synthesis of qualitative and quantitative evidence.
Integrate evidence to decision framework criteria, example questions and types of studies to potentially address these questions (derived from Rehfeuss et al 16 )
Domains of the WHO-INTEGRATE EtD framework | Examples of potential research question(s) that a synthesis of qualitative and/or quantitative evidence could address | Types of studies that could contribute to a review of qualitative and quantitative evidence |
Balance of benefits and harms | To what extent do patients/beneficiaries different health outcomes? | Qualitative: studies of views and experiences Quantitative: Questionnaire surveys |
Human rights and sociocultural acceptability | Is the intervention to patients/beneficiaries as well as to those implementing it? To what extent do patients/beneficiaries different non-health outcomes? How does the intervention affect an individual’s, population group’s or organisation’s , that is, their ability to make a competent, informed and voluntary decision? | Qualitative: discourse analysis, qualitative studies (ideally longitudinal to examine changes over time) Quantitative: pro et contra analysis, discrete choice experiments, longitudinal quantitative studies (to examine changes over time), cross-sectional studies Mixed-method studies; case studies |
Health equity, equality and non-discrimination | How is the intervention for individuals, households or communities? How —in terms of physical as well as informational access—is the intervention across different population groups? | Qualitative: studies of views and experiences Quantitative: cross-sectional or longitudinal observational studies, discrete choice experiments, health expenditure studies; health system barrier studies, cross-sectional or longitudinal observational studies, discrete choice experiments, ethical analysis, GIS-based studies |
Societal implications | What is the of the intervention: are there features of the intervention that increase or reduce stigma and that lead to social consequences? Does the intervention enhance or limit social goals, such as education, social cohesion and the attainment of various human rights beyond health? Does it change social norms at individual or population level? What is the of the intervention? Does it contribute to or limit the achievement of goals to protect the environment and efforts to mitigate or adapt to climate change? | Qualitative: studies of views and experiences Quantitative: RCTs, quasi-experimental studies, comparative observational studies, longitudinal implementation studies, case studies, power analyses, environmental impact assessments, modelling studies |
Feasibility and health system considerations | Are there any that impact on implementation of the intervention? How might , such as past decisions and strategic considerations, positively or negatively impact the implementation of the intervention? How does the intervention ? Is it likely to fit well or not, is it likely to impact on it in positive or negative ways? How does the intervention interact with the need for and usage of the existing , at national and subnational levels? How does the intervention interact with the need for and usage of the as well as other relevant infrastructure, at national and subnational levels? | Non-research: policy and regulatory frameworks Qualitative: studies of views and experiences Mixed-method: health systems research, situation analysis, case studies Quantitative: cross-sectional studies |
GIS, Geographical Information System; RCT, randomised controlled trial.
Questions can serve as an ‘anchor’ by articulating the specific aspects of complexity to be explored (eg, Is successful implementation of the intervention context dependent?). 27 Anchor questions such as “How does intervention x impact on socioeconomic inequalities in health behaviour/outcome x” are the kind of health system question that requires a synthesis of both quantitative and qualitative evidence and hence a mixed-method synthesis. Quantitative evidence can quantify the difference in effect, but does not answer the question of how . The ‘how’ question can be partly answered with quantitative and qualitative evidence. For example, quantitative evidence may reveal where socioeconomic status and inequality emerges in the health system (an emergent property) by exploring questions such as “ Does patterning emerge during uptake because fewer people from certain groups come into contact with an intervention in the first place? ” or “ are people from certain backgrounds more likely to drop out, or to maintain effects beyond an intervention differently? ” Qualitative evidence may help understand the reasons behind all of these mechanisms. Alternatively, questions can act as ‘compasses’ where a question sets out a starting point from which to explore further and to potentially ask further questions or develop propositions or hypotheses to explore through a complexity perspective (eg, What factors enhance or hinder implementation?). 27 Other papers in this series provide further guidance on developing questions for qualitative evidence syntheses and guidance on question formulation. 14 28
For anchor and compass questions, additional application of a theory (eg, complexity theory) can help focus evidence synthesis and presentation to explore and explain complexity issues. 17 21 Development of a review specific logic model(s) can help to further refine an initial understanding of any complexity-related issues of interest associated with a specific intervention, and if appropriate the health system or section of the health system within which to contextualise the review question and analyse data. 17 23–25 Specific tools are available to help clarify context and complex interventions. 17 18
If a complexity perspective, and certain criteria within evidence to decision frameworks, is deemed relevant and desirable by guideline developers, it is only possible to pursue a complexity perspective if the evidence is available. Careful scoping using knowledge maps or scoping reviews will help inform development of questions that are answerable with available evidence. 20 If evidence of effect is not available, then a different approach to develop questions leading to a more general narrative understanding of what happened when complex interventions were implemented in a health system will be required (such as in case study 3—risk communication guideline). This should not mean that the original questions developed for which no evidence was found when scoping the literature were not important. An important function of creating a knowledge map is also to identify gaps to inform a future research agenda.
Table 2 and online supplementary files 1–3 outline examples of questions in the three case studies, which were all ‘COMPASS’ questions for the qualitative evidence syntheses.
The shift towards integration of qualitative and quantitative evidence in primary research has, in recent years, begun to be mirrored within research synthesis. 29–31 The natural extension to undertaking quantitative or qualitative reviews has been the development of methods for integrating qualitative and quantitative evidence within reviews, and within the guideline process using evidence to decision-frameworks. Advocating the integration of quantitative and qualitative evidence assumes a complementarity between research methodologies, and a need for both types of evidence to inform policy and practice. Below, we briefly outline the current designs for integrating qualitative and quantitative evidence within a mixed-method review or synthesis.
One of the early approaches to integrating qualitative and quantitative evidence detailed by Sandelowski et al 32 advocated three basic review designs: segregated, integrated and contingent designs, which have been further developed by Heyvaert et al 33 ( box 3 ).
Segregated design.
Conventional separate distinction between quantitative and qualitative approaches based on the assumption they are different entities and should be treated separately; can be distinguished from each other; their findings warrant separate analyses and syntheses. Ultimately, the separate synthesis results can themselves be synthesised.
The methodological differences between qualitative and quantitative studies are minimised as both are viewed as producing findings that can be readily synthesised into one another because they address the same research purposed and questions. Transformation involves either turning qualitative data into quantitative (quantitising) or quantitative findings are turned into qualitative (qualitising) to facilitate their integration.
Takes a cyclical approach to synthesis, with the findings from one synthesis informing the focus of the next synthesis, until all the research objectives have been addressed. Studies are not necessarily grouped and categorised as qualitative or quantitative.
A recent review of more than 400 systematic reviews 34 combining quantitative and qualitative evidence identified two main synthesis designs—convergent and sequential. In a convergent design, qualitative and quantitative evidence is collated and analysed in a parallel or complementary manner, whereas in a sequential synthesis, the collation and analysis of quantitative and qualitative evidence takes place in a sequence with one synthesis informing the other ( box 4 ). 6 These designs can be seen to build on the work of Sandelowski et al , 32 35 particularly in relation to the transformation of data from qualitative to quantitative (and vice versa) and the sequential synthesis design, with a cyclical approach to reviewing that evokes Sandelowski’s contingent design.
Convergent synthesis design.
Qualitative and quantitative research is collected and analysed at the same time in a parallel or complementary manner. Integration can occur at three points:
a. Data-based convergent synthesis design
All included studies are analysed using the same methods and results presented together. As only one synthesis method is used, data transformation occurs (qualitised or quantised). Usually addressed one review question.
b. Results-based convergent synthesis design
Qualitative and quantitative data are analysed and presented separately but integrated using a further synthesis method; eg, narratively, tables, matrices or reanalysing evidence. The results of both syntheses are combined in a third synthesis. Usually addresses an overall review question with subquestions.
c. Parallel-results convergent synthesis design
Qualitative and quantitative data are analysed and presented separately with integration occurring in the interpretation of results in the discussion section. Usually addresses two or more complimentary review questions.
A two-phase approach, data collection and analysis of one type of evidence (eg, qualitative), occurs after and is informed by the collection and analysis of the other type (eg, quantitative). Usually addresses an overall question with subquestions with both syntheses complementing each other.
The three case studies ( table 1 , online supplementary files 1–3 ) illustrate the diverse combination of review designs and synthesis methods that were considered the most appropriate for specific guidelines.
In this section, we draw on examples where specific review designs and methods have been or can be used to explore selected aspects of complexity in guidelines or systematic reviews. We also identify other review methods that could potentially be used to explore aspects of complexity. Of particular note, we could not find any specific examples of systematic methods to synthesise highly diverse research designs as advocated by Petticrew et al 17 and summarised in tables 2 and 3 . For example, we could not find examples of methods to synthesise qualitative studies, case studies, quantitative longitudinal data, possibly historical data, effectiveness studies providing evidence of differential effects across different contexts, and system modelling studies (eg, agent-based modelling) to explore system adaptivity.
There are different ways that quantitative and qualitative evidence can be integrated into a review and then into a guideline development process. In practice, some methods enable integration of different types of evidence in a single synthesis, while in other methods, the single systematic review may include a series of stand-alone reviews or syntheses that are then combined in a cross-study synthesis. Table 1 provides an overview of the characteristics of different review designs and methods and guidance on their applicability for a guideline process. Designs and methods that have already been used in WHO guideline development are described in part A of the table. Part B outlines a design and method that can be used in a guideline process, and part C covers those that have the potential to integrate quantitative, qualitative and mixed-method evidence in a single review design (such as meta-narrative reviews and Bayesian syntheses), but their application in a guideline context has yet to be demonstrated.
Depending on the review design (see boxes 3 and 4 ), integration can potentially take place at a review team and design level, and more commonly at several key points of the review or guideline process. The following sections outline potential points of integration and associated practical considerations when integrating quantitative and qualitative evidence in guideline development.
In a guideline process, it is common for syntheses of quantitative and qualitative evidence to be done separately by different teams and then to integrate the evidence. A practical consideration relates to the organisation, composition and expertise of the review teams and ways of working. If the quantitative and qualitative reviews are being conducted separately and then brought together by the same team members, who are equally comfortable operating within both paradigms, then a consistent approach across both paradigms becomes possible. If, however, a team is being split between the quantitative and qualitative reviews, then the strengths of specialisation can be harnessed, for example, in quality assessment or synthesis. Optimally, at least one, if not more, of the team members should be involved in both quantitative and qualitative reviews to offer the possibility of making connexions throughout the review and not simply at re-agreed junctures. This mirrors O’Cathain’s conclusion that mixed-methods primary research tends to work only when there is a principal investigator who values and is able to oversee integration. 9 10 While the above decisions have been articulated in the context of two types of evidence, variously quantitative and qualitative, they equally apply when considering how to handle studies reporting a mixed-method study design, where data are usually disaggregated into quantitative and qualitative for the purposes of synthesis (see case study 3—risk communication in humanitarian disasters).
Clearly specified key question(s), derived from a scoping or consultation exercise, will make it clear if quantitative and qualitative evidence is required in a guideline development process and which aspects will be addressed by which types of evidence. For the remaining stages of the process, as documented below, a review team faces challenges as to whether to handle each type of evidence separately, regardless of whether sequentially or in parallel, with a view to joining the two products on completion or to attempt integration throughout the review process. In each case, the underlying choice is of efficiencies and potential comparability vs sensitivity to the underlying paradigm.
Once key questions are clearly defined, the guideline development group typically needs to consider whether to conduct a single sensitive search to address all potential subtopics (lumping) or whether to conduct specific searches for each subtopic (splitting). 36 A related consideration is whether to search separately for qualitative, quantitative and mixed-method evidence ‘streams’ or whether to conduct a single search and then identify specific study types at the subsequent sifting stage. These two considerations often mean a trade-off between a single search process involving very large numbers of records or a more protracted search process retrieving smaller numbers of records. Both approaches have advantages and choice may depend on the respective availability of resources for searching and sifting.
Closely related to decisions around searching are considerations relating to screening and selecting studies for inclusion in a systematic review. An important consideration here is whether the review team will screen records for all review types, regardless of their subsequent involvement (‘altruistic sifting’), or specialise in screening for the study type with which they are most familiar. The risk of missing relevant reports might be minimised by whole team screening for empirical reports in the first instance and then coding them for a specific quantitative, qualitative or mixed-methods report at a subsequent stage.
Within a guideline process, review teams may be more limited in their choice of instruments to assess methodological limitations of primary studies as there are mandatory requirements to use the Cochrane risk of bias tool 37 to feed into Grading of Recommendations Assessment, Development and Evaluation (GRADE) 38 or to select from a small pool of qualitative appraisal instruments in order to apply GRADE; Confidence in the Evidence from Reviews of Qualitative Research (GRADE-CERQual) 39 to assess the overall certainty or confidence in findings. The Cochrane Qualitative and Implementation Methods Group has recently issued guidance on the selection of appraisal instruments and core assessment criteria. 40 The Mixed-Methods Appraisal Tool, which is currently undergoing further development, offers a single quality assessment instrument for quantitative, qualitative and mixed-methods studies. 41 Other options include using corresponding instruments from within the same ‘stable’, for example, using different Critical Appraisal Skills Programme instruments. 42 While using instruments developed by the same team or organisation may achieve a degree of epistemological consonance, benefits may come more from consistency of approach and reporting rather than from a shared view of quality. Alternatively, a more paradigm-sensitive approach would involve selecting the best instrument for each respective review while deferring challenges from later heterogeneity of reporting.
The way in which data and evidence are extracted from primary research studies for review will be influenced by the type of integrated synthesis being undertaken and the review purpose. Initially, decisions need to be made regarding the nature and type of data and evidence that are to be extracted from the included studies. Method-specific reporting guidelines 43 44 provide a good template as to what quantitative and qualitative data it is potentially possible to extract from different types of method-specific study reports, although in practice reporting quality varies. Online supplementary file 5 provides a hypothetical example of the different types of studies from which quantitative and qualitative evidence could potentially be extracted for synthesis.
The decisions around what data or evidence to extract will be guided by how ‘integrated’ the mixed-method review will be. For those reviews where the quantitative and qualitative findings of studies are synthesised separately and integrated at the point of findings (eg, segregated or contingent approaches or sequential synthesis design), separate data extraction approaches will likely be used.
Where integration occurs during the process of the review (eg, integrated approach or convergent synthesis design), an integrated approach to data extraction may be considered, depending on the purpose of the review. This may involve the use of a data extraction framework, the choice of which needs to be congruent with the approach to synthesis chosen for the review. 40 45 The integrative or theoretical framework may be decided on a priori if a pre-developed theoretical or conceptual framework is available in the literature. 27 The development of a framework may alternatively arise from the reading of the included studies, in relation to the purpose of the review, early in the process. The Cochrane Qualitative and Implementation Methods Group provide further guidance on extraction of qualitative data, including use of software. 40
Relatively few synthesis methods start off being integrated from the beginning, and these methods have generally been subject to less testing and evaluation particularly in a guideline context (see table 1 ). A review design that started off being integrated from the beginning may be suitable for some guideline contexts (such as in case study 3—risk communication in humanitarian disasters—where there was little evidence of effect), but in general if there are sufficient trials then a separate systematic review and meta-analysis will be required for a guideline. Other papers in this series offer guidance on methods for synthesising quantitative 46 and qualitative evidence 14 in reviews that take a complexity perspective. Further guidance on integrating quantitative and qualitative evidence in a systematic review is provided by the Cochrane Qualitative and Implementation Methods Group. 19 27 29 40 47
It is highly likely (unless there are well-designed process evaluations) that the primary studies may not themselves seek to address the complexity-related questions required for a guideline process. In which case, review authors will need to configure the available evidence and transform the evidence through the synthesis process to produce explanations, propositions and hypotheses (ie, findings) that were not obvious at primary study level. It is important that guideline commissioners, developers and review authors are aware that specific methods are intended to produce a type of finding with a specific purpose (such as developing new theory in the case of meta-ethnography). 48 Case study 1 (antenatal care guideline) provides an example of how a meta-ethnography was used to develop a new theory as an end product, 48 49 as well as framework synthesis which produced descriptive and explanatory findings that were more easily incorporated into the guideline process. 27 The definitions ( box 5 ) may be helpful when defining the different types of findings.
Descriptive findings —qualitative evidence-driven translated descriptive themes that do not move beyond the primary studies.
Explanatory findings —may either be at a descriptive or theoretical level. At the descriptive level, qualitative evidence is used to explain phenomena observed in quantitative results, such as why implementation failed in specific circumstances. At the theoretical level, the transformed and interpreted findings that go beyond the primary studies can be used to explain the descriptive findings. The latter description is generally the accepted definition in the wider qualitative community.
Hypothetical or theoretical finding —qualitative evidence-driven transformed themes (or lines of argument) that go beyond the primary studies. Although similar, Thomas and Harden 56 make a distinction in the purposes between two types of theoretical findings: analytical themes and the product of meta-ethnographies, third-order interpretations. 48
Analytical themes are a product of interrogating descriptive themes by placing the synthesis within an external theoretical framework (such as the review question and subquestions) and are considered more appropriate when a specific review question is being addressed (eg, in a guideline or to inform policy). 56
Third-order interpretations come from translating studies into one another while preserving the original context and are more appropriate when a body of literature is being explored in and of itself with broader or emergent review questions. 48
A critical element of guideline development is the formulation of recommendations by the Guideline Development Group, and EtD frameworks help to facilitate this process. 16 The EtD framework can also be used as a mechanism to integrate and display quantitative and qualitative evidence and findings mapped against the EtD framework domains with hyperlinks to more detailed evidence summaries from contributing reviews (see table 1 ). It is commonly the EtD framework that enables the findings of the separate quantitative and qualitative reviews to be brought together in a guideline process. Specific challenges when populating the DECIDE evidence to decision framework 15 were noted in case study 3 (risk communication in humanitarian disasters) as there was an absence of intervention effect data and the interventions to communicate public health risks were context specific and varied. These problems would not, however, have been addressed by substitution of the DECIDE framework with the new INTEGRATE 16 evidence to decision framework. A d ifferent type of EtD framework needs to be developed for reviews that do not include sufficient evidence of intervention effect.
Mixed-method review and synthesis methods are generally the least developed of all systematic review methods. It is acknowledged that methods for combining quantitative and qualitative evidence are generally poorly articulated. 29 50 There are however some fairly well-established methods for using qualitative evidence to explore aspects of complexity (such as contextual, implementation and outcome complexity), which can be combined with evidence of effect (see sections A and B of table 1 ). 14 There are good examples of systematic reviews that use these methods to combine quantitative and qualitative evidence, and examples of guideline recommendations that were informed by evidence from both quantitative and qualitative reviews (eg, case studies 1–3). With the exception of case study 3 (risk communication), the quantitative and qualitative reviews for these specific guidelines have been conducted separately, and the findings subsequently brought together in an EtD framework to inform recommendations.
Other mixed-method review designs have potential to contribute to understanding of complex interventions and to explore aspects of wider health systems complexity but have not been sufficiently developed and tested for this specific purpose, or used in a guideline process (section C of table 1 ). Some methods such as meta-narrative reviews also explore different questions to those usually asked in a guideline process. Methods for processing (eg, quality appraisal) and synthesising the highly diverse evidence suggested in tables 2 and 3 that are required to explore specific aspects of health systems complexity (such as system adaptivity) and to populate some sections of the INTEGRATE EtD framework remain underdeveloped or in need of development.
In addition to the required methodological development mentioned above, there is no GRADE approach 38 for assessing confidence in findings developed from combined quantitative and qualitative evidence. Another paper in this series outlines how to deal with complexity and grading different types of quantitative evidence, 51 and the GRADE CERQual approach for qualitative findings is described elsewhere, 39 but both these approaches are applied to method-specific and not mixed-method findings. An unofficial adaptation of GRADE was used in the risk communication guideline that reported mixed-method findings. Nor is there a reporting guideline for mixed-method reviews, 47 and for now reports will need to conform to the relevant reporting requirements of the respective method-specific guideline. There is a need to further adapt and test DECIDE, 15 WHO-INTEGRATE 16 and other types of evidence to decision frameworks to accommodate evidence from mixed-method syntheses which do not set out to determine the statistical effects of interventions and in circumstances where there are no trials.
When conducting quantitative and qualitative reviews that will subsequently be combined, there are specific considerations for managing and integrating the different types of evidence throughout the review process. We have summarised different options for combining qualitative and quantitative evidence in mixed-method syntheses that guideline developers and systematic reviewers can choose from, as well as outlining the opportunities to integrate evidence at different stages of the review and guideline development process.
Review commissioners, authors and guideline developers generally have less experience of combining qualitative and evidence in mixed-methods reviews. In particular, there is a relatively small group of reviewers who are skilled at undertaking fully integrated mixed-method reviews. Commissioning additional qualitative and mixed-method reviews creates an additional cost. Large complex mixed-method reviews generally take more time to complete. Careful consideration needs to be given as to which guidelines would benefit most from additional qualitative and mixed-method syntheses. More training is required to develop capacity and there is a need to develop processes for preparing the guideline panel to consider and use mixed-method evidence in their decision-making.
This paper has presented how qualitative and quantitative evidence, combined in mixed-method reviews, can help understand aspects of complex interventions and the systems within which they are implemented. There are further opportunities to use these methods, and to further develop the methods, to look more widely at additional aspects of complexity. There is a range of review designs and synthesis methods to choose from depending on the question being asked or the questions that may emerge during the conduct of the synthesis. Additional methods need to be developed (or existing methods further adapted) in order to synthesise the full range of diverse evidence that is desirable to explore the complexity-related questions when complex interventions are implemented into health systems. We encourage review commissioners and authors, and guideline developers to consider using mixed-methods reviews and synthesis in guidelines and to report on their usefulness in the guideline development process.
Handling editor: Soumyadeep Bhaumik
Contributors: JN, AB, GM, KF, ÖT and ES drafted the manuscript. All authors contributed to paper development and writing and agreed the final manuscript. Anayda Portela and Susan Norris from WHO managed the series. Helen Smith was series Editor. We thank all those who provided feedback on various iterations.
Funding: Funding provided by the World Health Organization Department of Maternal, Newborn, Child and Adolescent Health through grants received from the United States Agency for International Development and the Norwegian Agency for Development Cooperation.
Disclaimer: ÖT is a staff member of WHO. The author alone is responsible for the views expressed in this publication and they do not necessarily represent the decisions or policies of WHO.
Competing interests: No financial interests declared. JN, AB and ÖT have an intellectual interest in GRADE CERQual; and JN has an intellectual interest in the iCAT_SR tool.
Patient consent: Not required.
Provenance and peer review: Not commissioned; externally peer reviewed.
Data sharing statement: No additional data are available.
Supplemental material: This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.
BMC Veterinary Research volume 20 , Article number: 381 ( 2024 ) Cite this article
92 Accesses
1 Altmetric
Metrics details
Bovine leukemia virus (BLV) is the etiological agent of enzootic bovine leukosis and causes a persistent infection that can leave cattle with no symptoms. Many countries have been able to successfully eradicate BLV through improved detection and management methods. However, with the increasing novel molecular detection methods there have been few efforts to standardize these results at global scale. This study aimed to determine the interlaboratory accuracy and agreement of 11 molecular tests in detecting BLV. Each qPCR/ddPCR method varied by target gene, primer design, DNA input and chemistries. DNA samples were extracted from blood of BLV-seropositive cattle and lyophilized to grant a better preservation during shipping to all participants around the globe. Twenty nine out of 44 samples were correctly identified by the 11 labs and all methods exhibited a diagnostic sensitivity between 74 and 100%. Agreement amongst different assays was linked to BLV copy numbers present in samples and the characteristics of each assay (i.e., BLV target sequence). Finally, the mean correlation value for all assays was within the range of strong correlation. This study highlights the importance of continuous need for standardization and harmonization amongst assays and the different participants. The results underscore the need of an international calibrator to estimate the efficiency (standard curve) of the different assays and improve quantitation accuracy. Additionally, this will inform future participants about the variability associated with emerging chemistries, methods, and technologies used to study BLV. Altogether, by improving tests performance worldwide it will positively aid in the eradication efforts.
Peer Review reports
Bovine leukemia virus (BLV) is a deltaretrovirus from the Orthoretrovirinae subfamily of the Retroviridae family. An essential step in the BLV replication cycle is the integration of DNA copy of its RNA genome into the DNA of a host cell [ 1 ]. Once integrated, the proviral DNA is replicated along with the host’s DNA during cellular divisions, as for any cellular gene. The BLV is the etiologic agent of enzootic bovine leukosis (EBL). BLV causes a persistent infection in cattle, and in most cases this infection is asymptomatic [ 2 ]. In one-third of infected animals the infection progresses to a state of persistent lymphocytosis, and in 1 to 10% of infected cattle it develops into lymphosarcoma [ 2 ]. BLV induces high economic losses due to trade restrictions, replacement cost, reduced milk production, immunosuppression, and increased susceptibility to pneumonia, diarrhea, mastitis, and so on [ 3 , 4 , 5 , 6 ]. BLV is globally distributed with a high prevalence, except for Western Europe and Oceania, where the virus has been successfully eradicated through detection and elimination of BLV-infected animals [ 7 , 8 ]. The agar gel immunodiffusion and ELISA for the detection of BLV-specific antibodies in sera and milk are the World Organization for Animal Health (WOAH, founded as OIE) prescribed tests for serological diagnosis but ELISA, due to its high sensitivity and ability to test many samples at a very low cost, is highly recommended [ 9 ]. Despite the advantages of serologic testing, there are some scenarios in which direct detection of the BLV genomic fragment was important to improve BLV detection. The most frequent cases is the screening of calves with maternal antibodies, acute infection, animals without persistent antibody response and animal subproducts (i.e., semen). In this regard, nucleic acid amplification tests such as real-time quantitative PCR (qPCR) allows for a rapid and highly sensitive detection of BLV proviral DNA (BLV DNA) that can be used to test infected and asymptomatic animals, before the elicitation of anti-BLV specific antibodies and when proviral load (PVL) are still low [ 10 ]. Furthermore, qPCR assays can serve as confirmatory tests for the clarification of inconclusive and discordant serological test results usually associated with these cases [ 11 ]. For these reasons, the inclusion of qPCR in combination with other screening tests might increase control programs efficiency. Additionally, qPCR allows the estimation of BLV PVL which is important for studying the dynamics of BLV infection (i.e., basic research). Further, considering that BLV PVL correlates with the risk of BLV transmission, this feature of qPCR can be exploited for developing rational segregation programs [ 12 , 13 ]. The results of Kobayashi et al. suggest that high PVL is also a significant risk factor for progression to EBL and should therefore be used as a parameter to identify cattle for culling from the herd well before EBL progression [ 14 ]. Several qPCRs have been developed globally for the quantitation of BLV DNA. Although most assays have been properly validated by each developer, a proper standardization and harmonization of such tests is currently lacking. Considering that standardization and harmonization of qPCR methods and results are essential for comparisons of data from BLV laboratories around the world, this could directly impact international surveillance programs and collaborative research. We built a global collaborative network of BLV reference laboratories to evaluate the interlaboratory variability of different qPCRs and sponsored a harmonization of assays to hopefully impact international surveillance programs and research going forward.
In 2018 we conducted the first global trial of this kind to assess the interlaboratory variability of six qPCRs for the detection of BLV DNA [ 15 ]. Since this complex process is a continuous rather than a one-time effort, we now started a second study of this type. In this follow up study, we built a more comprehensive sample panel, accounting for a broader geographical diversification. Additionally, we increased the number of participants to ten collaborating laboratories plus one WOAH reference lab and tested novel methodologies including digital PCR (ddPCR) and FRET-qPCR. Finally, we established the next steps towards the international standardization of molecular assays for the detection of BLV DNA.
Participants.
The eleven laboratories that took part in the study were:(i) the Auburn University College of Veterinary Medicine (Auburn, Alabama, United States): (ii) AntelBio, a division of CentralStar Cooperative (Michigan, United States); (iii) Laboratórios Federais de Defesa Agropecuária de Minas Gerais (LFDA-MG, Pedro Leopoldo, Brasil); (iv) Centro de Investigación Veterinaria de Tandil (CIVETAN, Buenos Aires, Argentina); (v) the Faculty of Agriculture Iwate University (Iwate, Japan); (vi) Universidad de la República de Uruguay (UdelaR, Montevideo, Uruguay); (vii) the Croatian Veterinary Institute (Zagreb, Croatia); (viii) Instituto Nacional de Tecnología Agropecuaria (INTA, Buenos Aires, Argentina); (ix) Laboratorio Central de Veterinaria (LCV, Madrid, Spain); (x) the National Veterinary Research Institute (NVRI, Puławy, Poland) and (xi) the French Agency for Food, Environmental and Occupational Health and Safety (Anses, Niort, France). All European laboratories participating in this study are acting as national reference laboratories for EBL, NVRI acts as WOAH reference laboratory for EBL, while the remaining laboratories are nationally renowned entities for BLV diagnostics. The eleven participating methods are referred to below as qPCR1 – qPCR5, ddPCR6, qPCR7 – qPCR11, respectively.
A total of 42 DNA samples obtained from blood of naturally BLV-infected dairy cattle from Poland, Moldova, Pakistan, Ukraine, Canada and United States were used for this study. Thirty-six of them were archival DNA samples obtained between 2012–2018 as described in our previous studies on samples from Poland ( n = 21) [ 16 , 17 ], Moldova ( n = 4) [ 18 ], Pakistan ( n = 5) [ 19 ] and Ukraine ( n = 6) [ 15 , 20 ]. Between 2020–2021 6 peripheral blood and serum samples from naturally BLV-infected cattle were obtained from three dairy farms of Alberta, Canada and two dairy farms of Michigan, US. Serological testing and sample processing were conducted by the laboratories from which the samples originated. The genomic DNA from Canadian and US samples was extracted from whole blood using a Quick DNA Miniprep Plus kit (Zymo Research) and a DNeasy Blood & Tissue Kit (Qiagen), respectively in University of Calgary and Michigan State University and sent to the NVRI in the form of DNA solutions. Additionally, one plasmid DNA sample (pBLV344) was kindly supplied by Luc Willems (University of Liège, Belgium) and DNA extracted from FLK-BLV cells were included as positive controls. Finally, DNA extracted from PBL of a serologically negative cattle was included as negative control. At the NVRI, the DNA concentration in all samples was estimated by spectrophotometry using a NanoPhotometer (Implen). Each sample was divided into eleven identical aliquots containing between 800 and 4,000 ng of lyophilised genomic DNA. Eleven identical sets of these samples were lyophilized (Alpha 1–4 LSC basic, Martin Christ Gefriertrocknungsanlagen GmbH) and distributed to participating laboratories. At the NVRI, all samples were coded (identification [ 21 ] run numbers 1 to 44) to perform a blinded testing. The samples, together with instructions for their preparation (Additional file 1), were shipped by air at room temperature (RT).
Since different extraction methods and lyophilization process were employed for the preparation of the DNA samples, it was necessary to test the quality of the DNA at the NVRI laboratory. For that purpose, one complete set of samples ( n = 44) was tested by Fragment Analyzer (Agilent Technologies), before and after freeze-drying, to assess DNA quality by calculating a Genomic Quality Number (GQN) for every sample. Low GQN value (< 2.5) represents sheared or degraded DNA. A high GQN (> 9) represents undegraded DNA. In addition, quality of DNA was assessed by determination of copy number of the histone H3 family 3A ( H3F3A ) housekeeping gene using quantitative real-time PCR (qPCR) [ 22 ]. The qPCR results were expressed as the number of H3F3A gene copies per 300 ng of DNA in each sample. Grubbs´ test was performed to determine outliers. To test the stability of DNA, samples were stored for 20 days at RT (10 days) and at + 4 °C (10 days) and were retested by Fragment Analyzer and qPCR 21 days later. A Mann–Whitney U-test was used to compare the median values between fresh and stored samples (time 0 and time 1), respectively.
All participating laboratories performed their qPCR or ddPCR using a variety of different equipment, reagents, and reaction conditions, which had been set up, validated, and evaluated previously and are currently used as working protocols. The specific features of each of these protocols are described below and summarized in Table 1 .
All laboratories applied standard procedures for avoiding false-positive results indicative of DNA contamination, such as the use of separate rooms for preparing reaction mixtures, adding the samples, and performing the amplification reaction. One of the ten BLV qPCRs used LTR region and the remaining nine qPCRs used the pol gene as the target sequence for amplification, while the ddPCR amplified the env gene.
The BLV qPCR amplifying a 187-bp pol gene was performed according to a previously published methods [ 23 , 24 ]. A real-time fluorescence resonance energy transfer (FRET) PCR was carried out in a 20-μl PCR mixture containing 10 μl handmade reaction master mix and 10 μl genomic DNA. The PCR buffer was 4.5 mM MgCl2, 50 mM KCl, 20 mM Tris–HCl, pH 8.4, supplemented with 0.05% each Tween20 and Non-idet P-40, and 0.03% acetylated BSA (Roche Applied Science). For each 20 μl total reaction volume, the nucleotides were used at 0.2 mM each and 1.5 U Platinum Taq DNA polymerase (Invitrogen, Carlsbad, CA, USA) was used. Primers were used at 1 μM, LCRed640 probe was used at 0.2 μM, and 6-FAM probe was used at 0.1 μM. Amplification was performed in the Roche Light Cycler 480 II (Roche Molecular Biochemicals) using 10 min denaturation step at 95 °C, followed by 18 high-stringency step-down thermal cycles and 30 low-stringency fluorescence acquisition cycles.
A plasmid containing the BLV-PCR amplicon region was diluted ten-fold from 1 × 10 5 copies to 10 copies per 10 µl and was used as a standard to measure the BLV copy numbers.
A BLV proviral load qPCR assay developed by AntelBio, a division of CentralStar Cooperative Inc. on Applied Biosystems 7500 Real-Time PCR system [ 25 , 33 ]. This multiplex assay amplifies the BLV pol gene along with the bovine β-actin gene and an internal amplification control, “Spike”. A quantitative TaqMan PCR was carried out in a 25-μl PCR mixture containing 12.5 µl of 2X InhibiTaq Multiplex HotStart qPCR MasterMix (Empirical Bioscience), 16 nM each BLV primer, 16 nM each β-actin primer, 8 nM each spike primer, 8 nM BLV FAM-probe, 8 nM β-actin Cy5-probe, 4 nM spike JOE-probe, 1 µl of an internal spike-in control (10,000 copies per µl), 7.25 µl of nuclease-free water and 4 µl of DNA sample for each qPCR reaction. The thermal PCR protocol was as follows: 95 °C for 10 min, 40 × (95 °C for 15 s, 60 °C for 1 min). Copy numbers of both the BLV pol gene and bovine β-Actin were derived using a plasmid containing target sequences, quantified by ddPCR, diluted 1 × 10 6 copies per µl to 10 copies per µl in tenfold dilutions. DNA concentrations of each sample were measured using a Qubit 4 Fluorometer and used in combination with the qPCR copy numbers to calculate BLV copies per 100 ng.
The qPCR assays for the BLV LTR gene were performed according to a previously published methods [ 26 ]. Genomic DNA was amplified by TaqMan PCR with 10 μl of GoTaq Probe qPCR Master Mix × 2 (Promega), 0.6 pmol/μl each primer, 0.3 pmol/µl double-quenched probe and 100 ng genomic DNA. Amplification was performed in the CFX96 cycler (BioRad) according to the protocol: 5 min denaturation at 95°C followed by 45 cycles (60 s at 94°C and 60 s at 60°C). The efficiency of each reaction was calculated from the serial dilution of DNA extracted from BLV persistently infected fetal lamb kidney (FLK) cells, starting at a concentration of 100 ng/µl [ 21 ]. The detection limit was tested using a plasmid containing the target of the qPCRs, starting at 10 3 ng/µl.
The quantitative real-time PCR was done with the primers for the BLV pol gene as previously described [ 34 ]. The qPCR reaction mix contained 1 × PCR Master Mix with SYBR Green (FastStart Universal SYBR Green Master Rox, Roche), 0.3 μM each primer and 30 ng of extracted genomic DNA. Amplification was performed in QuantStudio 5 Real-Time PCR System (Applied Biosystems) under the following conditions: 2 min at 50 °C, 10 min at 95 °C, 40 cycles of 15 s at 95 °C and 60 s at 60 °C. A standard curve of six tenfold serial dilutions of pBLV, containing 1 × 10 6 to 10 BLV copies, was built and run 3 times for validation of the method. The number of provirus copies per reaction (100 ng) was calculated.
BLV PVLs were determined by using qPCR kit, RC202 (Takara Bio, Shiga, Japan) [ 28 , 35 ]. This qPCR assay amplifies the BLV pol gene along with the bovine RPPH1 gene as an internal control. Briefly, 100 ng genomic DNA was amplified by TaqMan PCR with four primers for pol gene and RPPH1 gene according to the manufacturer’s instructions: 30 s denaturation at 95 °C followed by 45 cycles (5 s at 95 °C and 30 s at 60 °C). The qPCR was performed on a QuantStudio 3 Real-Time PCR System (Thermo Fisher Scientific K.K., Tokyo, Japan). Standard curve was generated by creating tenfold serial dilutions of the standard plasmid included in the kit. The standards for calibration ranged from 1 to 10 6 copies/reaction and were run in duplicate. The number of provirus copies per 100 ng was calculated.
The digital droplet PCR (ddPCR) assay for the env gene of the BLV was performed using the protocol previously described by [ 28 , 29 ]. An absolute quantification by TaqMan ddPCR was performed in a typical 20-μl assay, 1 μl of DNA sample was mixed with 1 μl of each primer (10 μM), 0.5 μl of probe (10 μM), and 2 × Supermix emulsified with oil (Bio-Rad). The droplets were transferred to a 96-well plate (Eppendorf). The PCR assay was performed in a thermocycler (C1000 touch cycler; Bio-Rad) with the following parameters: initial denaturation of 10 min at 95 °C, then 40 cycles of 30 s at 94 °C, and 1 min at 58 °C, with final deactivation of the enzyme for 10 min at 98 °C. The presence of fluorescent droplets determined the number of resulting positive events that were analyzed in the software (QuantaSoft v.1.7.4; Bio-Rad), using dot charts. The number of provirus copies per 100 ng were calculated. Each sample was run in duplicate, and results were averaged.
This qPCR method for the BLV pol gene is a modified option of widely available quantitative TaqMan qPCR described by Rola-Łuszczak et al. [ 11 ], using the same primers and standards. A quantitative TaqMan PCR was performed in a 20 μl PCR mix containing 10 μl of 2 × ORA qPCR Probe ROX L Mix (highQu, Kraichtal, Germany), 2 μl primer/probe mix (final concentration 400 nM of each of the primers, 200 nM of BLV probe), and 3 μl extracted genomic DNA. Amplification was performed in the Rotor-Gene Q system (Qiagen) with an initial denaturation step and polymerase activation at 95 °C for 3 min, followed by 45 cycles of 95 °C for 5 s and 60 °C for 30 s. As a standard, plasmid pBLV1 (NVRI, Pulawy, PL) containing a BLV pol fragment was used. Tenfold dilutions of plasmid DNA were made from 1 × 10 10 copies to 1 × 10 1 copies per reaction and used to generate the standard curve and estimate BLV copy number per 100 ng.
Proviral load quantification was assessed by SYBR Green real-time quantitative PCR (qPCR) using the pol gene as the target sequence [ 36 ]. Briefly, 12-μl PCR mixture contained Fast Start Universal SYBR Green Master Mix (Roche), 800 nM each BLV pol primers and 1 µl DNA as template. The reactions were incubated at 50 °C for 2 min and 95 °C for 10 min, followed by 40 cycles at 95 °C for 15 s, 55 °C for 15 s and 60 °C for 1 min. All samples were tested in duplicate on a StepOne Plus machine (Applied Biosystems). A positive and negative control, as well as a no-template control, were included in each plate. After the reaction was completed, the specificity of the amplicons was checked by analyzing the individual dissociation curves. As a standard, plasmid pBLV1 (NVRI, Pulawy, PL) containing a BLV pol fragment was used. Tenfold dilutions of plasmid DNA were made from 1 × 10 6 to 10 copies per µl and used to generate the standard curve and estimate BLV copy number per 100 ng.
This qPCR method is a modified option of widely available quantitative TaqMan qPCR described by Rola-Łuszczak et al. [ 11 ], using the same primers and standards. The detection of BLV genome was combined with an endogenous control system (Toussaint 2007) in a duplex assay. Briefly, 20-µl qPCR reaction contained AhPath ID™ One-Step RT-PCR Reagents with ROX (Applied Biosystems, CA, USA) – 10 µl of 2 × RT-PCR buffer and 0.8 µl of 25 × RT-PCR enzyme mix, 400 nM each primer for pol gene, 100 nM BLV specific probe, 40 nM each β-actin primer, 40 nM β-actin specific probe and 2 µl DNA sample. All samples were tested in ABI7500 Real-Time PCR System (Applied Biosystems) according to the following protocol: 10 min at 48 °C (reverse transcription), 10 min at 95 °C (inactivation reverse transcriptase / activation Taq polymerase) followed by 45 cycles (15 s at 95 °C and 60 s at 60 °C). As a standard, plasmid pBLV1 (NVRI, Pulawy, PL) containing a BLV pol fragment was used. Tenfold dilutions of plasmid DNA were made from 1 × 10 4 copies to 0.1 copies per μl and used to generate the standard curve and estimate BLV copy number per 100 ng.
The BLV qPCR was performed as published previously [ 11 ]. A quantitative TaqMan PCR was carried out in a 25-μl PCR mixture containing 12.5 μl of 2 × QuantiTect Multiplex PCR NoROX master mix (Qiagen), 0.4 μM each primer, 0.2 μM specific BLV probe, and 500 ng of extracted genomic DNA. Amplification was performed in the Rotor-Gene Q system (Qiagen) using an initial denaturation step and polymerase activation at 95 °C for 15 min, followed by 50 cycles of 94 °C for 60 s and 60 °C for 60 s. All samples were amplified in duplicate. As a standard, the pBLV1 plasmid (NVRI, Pulawy, PL), containing a 120-bp BLV pol fragment, was used. Tenfold dilutions of this standard were made from 1 × 10 6 copies per μl to 100 copies per μl and were used to estimate the BLV copy numbers per 100 ng.
This qPCR method for the BLV pol gene is a modified option of widely available quantitative TaqMan qPCR described by Rola-Łuszczak et al. [ 11 ], using the same primers and standards. The reaction mixture contained 400 nM of each primer, 200 nM of probe, 10 µl of 2 × SsoFast probes supermix (Bio-Rad), 5 µl of DNA sample and H 2 O up to 20 µl of the final volume. PCR assays were carried out on a CFX96 thermocycler (Bio-Rad) under the following amplification profile: 98 °C for 3 min, followed by 45 cycles of 95 °C for 5 s and 60 °C for 30 s. As a standard, plasmid pBLV1 (NVRI, Pulawy, PL) containing a BLV pol fragment was used. Tenfold dilutions of plasmid DNA were used to generate the standard curve and estimate BLV copy number per 100 ng.
In order to assess full-length pol , env and LTR sequence variability among BLV genotypes, all BLV sequences ( n = 2191) available on 30 September 2023 in GenBank ( https://www.ncbi.nlm.nih.gov/GenBank/ ) repository were retrieved. From the collected sequences, 100 pol , env and LTR sequences, which were characterized by the highest level of sequence variability and divergence, were selected for the further analysis. A pol -based, env -based and LTR-based maximum likelihood (ML) phylogenetic trees (see Additional file 6) was constructed to assign genotypes to the unassigned BLV genomes [ 37 , 38 , 39 ]. For all genes and LTR region the Tamura-Nei model and Bootstrap replications (1,000) were applied. In this analysis, pol sequences were assigned to 7 BLV genotypes (G1, G2, G3, G4, G6, G9, and G10), while env and LTR sequences were assigned to 10 BLV genotypes (G1, G2, G3, G4, G5, G6, G7, G8, G9, and G10). Phylogeny of the same isolates assigned to particular genotypes by ML method was confirmed by Mr. Bayes analysis [ 40 , 41 , 42 ] (data not shown). From this analysis, a total of 100 full-length pol, env and LTR sequences were used for multiple-sequence alignment (MSA) using ClustalW algorithm, implemented in MEGA X. For all sequences, nucleotide diversity (π), defined as the average number of nucleotide differences per site between two DNA sequences in all possible pairs in the sample population, was estimated using MEGA X. To measure the relative variation in different positions of aligned genes and LTR region the Shannon’s entropy (a quantitative measure of diversity in the alignment, where H = 0 indicates complete conservation) was estimated using BioEdit v. 7.2.5 software 64. The statistical analyses were performed using DATAtab e.U. Graz, Austria and GraphPad Software by Dotmatics, Boston.
To test the quality of DNA samples, the H3F3A copy number of each individual sample was assessed by qPCR at the NVRI. Copy numbers were normalized to DNA mass input and results were expressed as copy numbers per 300 ng of total DNA. The respective values were tested by Grubbs' test. The results for 43 DNA samples (sample ID: 42 with BLV genome plasmid was excluded) followed a normal distribution (Shapiro–Wilk 0.97; P = 0.286), with a mean value of 35,626 copies (95% confidence interval [ 43 ] 33,843 to 37,408 copies), a minimum value of 19,848 copies and a maximum value of 46,951 copies (see Additional file 2). Despite a low value for sample ID: 40 no significant outlier was detected in the dataset ( P > 0.05). Therefore, it can be assumed that the DNA quality was acceptable for all samples present in the panel. Next, DNA stability was assessed by retesting the H3F3A copy numbers in each sample ( n = 43) after a combined storage consisting in 10 days at RT and 10 days at + 4°C. A Mann–Whitney U-test was used to compare the median values between fresh and stored samples (time 0 and time 1, respectively), and no significant difference was observed at the 5% level ( P = 0.187) (Fig. 1 A).
Assessment of the stability of DNA samples. A Shown are copy numbers of the H3F3A housekeeping gene in 43 DNA samples that were stored in 10 days at RT and 10 days at + 4°C and tested twice with a 21-day interval. A Mann–Whitney U-test was used to compare the median values between two groups ( P = 0.187); B Shown are GQN values ( n = 43) tested twice with a 21-day interval: `before freeze-drying` and `after freeze-drying`. A Mann–Whitney U-test results between two groups ( P = 0.236)
In addition, the quality of DNA samples after lyophilization was analyzed. DNA from individual samples ( n = 43) was assessed with the genomic DNA quality number on the Fragment Analyzer system. The GQN from all lyophilized samples ranged from 4.0 to 9.7—that represented undegraded DNA. There was no significant difference in GQN values between `before freeze-drying` and `after freeze-drying` groups with respect to the corresponding DNA samples ( P = 0.236) (Fig. 1 B). Altogether, these results suggested that sample storage, lyophilization and shipping has a minimal impact in DNA stability and further testing during the interlaboratory trial.
A total of 44 DNA samples, including two positive (ID: 42 and 43) and one negative (ID: 32) controls, were blinded and independently tested by eleven laboratories using their own qPCR methods (Table 2 ). All laboratories measured the concentration of DNA in samples (Additional file 3). BLV provirus copy number was normalized to DNA concentration and expressed per 100 ng of genomic DNA for each test.
Except for the positive (pBLV344 and FLK cell line) and the negative controls, all samples had previously shown detectable levels of BLV-specific antibodies (BLV-Abs) by enzyme-linked immunosorbent assays (ELISA). During the current interlaboratory study, both the positive and negative controls were assessed adequately by all eleven PCR tests. Of all 43 positive samples, 43, 35, 37, 36, 40, 32, 40, 42, 42, 42 and 41 samples were detected as positive by the qPCR1, qPCR2, qPCR3, qPCR4, qPCR5, ddPCR6, qPCR7, qPCR8, qPCR9, qPCR10 and qPCR11 methods, respectively. Based on these observations, the most sensitive method was the qPCR1, and the method with the lowest sensitivity was the ddPCR6. Twenty-nine out of 44 samples were identified correctly by all qPCRs. The remaining 15 samples gave discordant results. Comparison of qualitative results (positive versus negative) from all eleven methods revealed 87.33% overall agreement and a kappa value of 0.396 (Cohen's kappa method adapted by Fleiss) [ 44 , 45 ]. The levels of agreement among the results from the eleven methods are represented in Table 3 . The maximum agreement was seen between two methods (qPCR9 and qPCR10 [100% agreement and a Cohen's kappa value of 1.000]) that used similar protocols and targeted the same region of BLV pol .
Due to differences in performance observed among the pol -based qPCR assays (the qPCR1, qPCR2, qPCR4, qPCR5 and qPCR7- qPCR11 methods), and considering that the env -based ddPCR6 and LTR-based qPCR3 assay showed the lowest sensitivity and the poorest agreement with the other assays, the degree of sequence variability between the pol , env and LTR genes was addressed. From the MSAs for pol , env and LTR, the nucleotide diversity (π) was calculated. The π value for pol gene was lower than that for LTR and env gene (π pol , 0.023 [standard deviation {SD}, 0.018]; π LTR , 0.024 [SD, 0.011]; π env , 0.037 [SD, 0.013]). From this analysis, pol sequences appeared to be less variable than env and LTR sequences. In addition, we performed a Shannon entropy-based per-site variability profile of the pol , env and LTR sequences used in this study (Fig. 2 A-C).
Sequence variability measured as per-site entropy. A Multiple alignment of the pol gene showing the locations of qPCR fragments in regions of the pol gene for the qPCR1 (highlighted in pink), qPCR4 (highlighted in yellow) and for the qPCR7, qPCR8, qPCR9, qPCR10 and qPCR11 assays (highlighted in orange). B Multiple alignment of the env gene targeted by ddPCR6 (highlighted by blue rectangle). C Multiple alignment of the LTR region by qPCR3 (highlighted in mint)
The all-observed entropy plots were homogeneous along the whole sequences. Considering the three regions of pol gene, the highest entropy (4.67) occurred in the region targeted by the qPCR1 primers, whereas the entropy for qPCR7—qPCR11 and qPCR4 primers were 1.57 and 0.38, respectively. For the LTR region targeted by qPCR3 primers and for env gene targeted by ddPCR6, the total entropy was equal to 4.46 and 7.85, respectively. This analysis showed a marked region of variability for LTR and env fragments. Interestingly, we noted that the qPCR7—qPCR11 targeted the most conserved regions of reverse transcriptase and qPCR4 primers targeted the most-conserved region of virus integrase (Fig. 2 A-C; see also Additional file 7).
To analyze whether the range of copy numbers detected by each qPCR was comparable to those of the others, Kruskal–Wallis one-way analysis of variance (ANOVA) was used. The violin plots were used to visualize the ANOVA results (Fig. 3 A-B).
Comparison of detection of BLV proviral DNA copy numbers by eleven testing methods. Shown is a box plot of data from Kruskal–Wallis ANOVA, a rank test. The DNA copy numbers for 41 samples, determined independently by each of the 11 qPCRs, were used for the variance analysis. In this analysis, the positive controls (sample ID 42 and ID 43) and negative control (sample ID 32) were excluded. A Violin plot for graphical presentation of the ANOVA of proviral copy number values. B Violin plot for ANOVA analysis of variance, copy number values are presented on a logarithmic scale (Log1.2) for better illustration of copy number differences between PCR methods
The grouping variable revealed significant differences among the distributions of proviral DNA copy numbers with the various qPCRs ( P < 0.001). These results showed that the abilities of qPCRs/ddPCR to determine the proviral DNA copy number differed. A Dunn-Bonferroni test was used to compare the groups in pairs to find out which was significantly different. The Dunn-Bonferroni test revealed that the pairwise group comparisons of qPCR2—qPCR4, qPCR3—ddPCR6, qPCR4—qPCR5, qPCR4—ddPCR6, qPCR4—qPCR9, qPCR4—qPCR10, qPCR5—qPCR11, ddPCR6—qPCR11 and qPCR9—qPCR11 have an adjusted P value less than 0.05 and thus, it can be assumed that these groups were significantly different in each pair (see Additional file 4). The Pareto chart was used to show the average copy number values of all methods in descending order. These Pareto charts were prepared based on 80–20 rule, which states that 80% of effects come from 20% of the various causes [ 46 ]. The methods that generated the highest copy numbers was qPCR3 and qPCR4, on the other hand the lowest copy numbers and/or highest negative results were generated by ddPCR6 (Fig. 4 ).
A Pareto chart with the proviral BLV copy mean values for eleven PCR assay arranged in descending order. Pareto charts was prepared based on 80–20 rule, which states that 80% of effects come from 20% of the various causes
The correlations between copy numbers detected by different qPCRs and ddPCR assays were calculated. The Kendall's Tau correlation coefficient measured between each pair of the assays was shown in the Additional file 5 and in Fig. 5 as a correlation heatmap. The average correlation for all qPCRs and ddPCR assays was strong (Kendall's tau = 0.748; P < 0.001).
The heatmap of Kendall’s tau correlation coefficients between copy numbers detected by ten qPCRs and one ddPCR. Statistically significant differences in the distribution of copy numbers, a moderate, strong and very strong correlation between particular qPCRs/ddPCR was observed. The strength of the association, for absolute values of r, 0–0.19 is regarded as very weak, 0.2–0.39 as weak, 0.40–0.59 as moderate, 0.6–0.79 as strong and 0.8–1 as very strong correlation
Since the differences between PCR tests may be influenced by the number of BLV proviral copies present in each sample, we compared the average number of BLV copies between a group of genomic DNA samples that gave concordant results (group I [ n = 28]) and a group that gave discordant results (group II [ n = 15]). The mean number of copies was 73,907 (minimum, 0; maximum, 4,286,730) in group I, and 3,479 (minimum, 0; maximum, 218,583) in group II, and this difference was statistically significant ( P < 0.001 by a Mann–Whitney U- test) (Fig. 6 ).
Impact of BLV proviral copy numbers on the level of agreement. Violin plot for graphical presentation of Mann–Whitney U test. The test was performed to compare BLV provirus copy number in two groups of samples: 28 samples with fully concordant results from all eleven qPCR/ddPCR assays (left) and 15 samples with discordant results from different qPCR/ddPCR assays (right) ( P < 0.001). Sample ID 42 was excluded from the statistical analysis
The results show that the concordant results group had considerably higher copy numbers (median, 5,549.0) than the discordant results group (median, 6.3).
BLV control and eradication programs consist of correct identification and subsequent segregation/elimination of BLV-infected animals [ 47 ]. Detection of BLV- infected cows by testing for BLV-specific antibodies in serum by agar gel immunodiffusion and ELISA is the key step and standard to be implemented of EBL eradication programs according to WOAH ( https://www.woah.org/en/disease/enzootic-bovine-leukosis/) [ 9 ]. Despite the low cost and high throughput of serological tests, there are several scenarios where highly specific and sensitive molecular assays for the detection of BLV DNA might improve detection and program efficiency.
In this perspective, qPCR assays can detect small quantities of proviral DNA during acute infection, in which animals show very low levels of anti-BLV antibodies [ 43 , 48 , 49 , 50 ]. qPCR methods can also work as confirmatory tests to clarify ambiguous and inconsistent serological test results [ 11 ]. Such quantitative features of qPCRs are crucial when eradication programs progress and prevalence decreases. Moreover, qPCR allows not only the detection of BLV infection but also estimation of the BLV PVL, which directly correlates with the risk of disease transmission [ 51 , 52 ]. This feature of qPCR allows for a rational segregation of animals based on the stratified risk of transmission. These considerations allow for greater precision in the management of BLV within large herds with a high prevalence of BLV ELISA-positive animals to effectively reduce herd prevalence [ 13 , 53 ]. BLV is a global burden and the lack of technical standardization of molecular detection systems remains a huge obstacle to compare surveillance data globally based on the first interlaboratory trial performed in 2018 [ 15 ]. In the 2018 study we observed an adjusted level of agreement of 70% comparing qualitative qPCR results; however, inconsistencies amongst methods were larger when low number of copies of BLV DNA were compared. Samples with low copies of BLV DNA (< 20 copies per 100 ng) accounted for the higher variability and discrepancies amongst tests. We concluded from the first interlaboratory trial that standardizing protocols to improve sensitivity of assays with lower detection rates was necessary.
In this follow up study, we re-tested the TaqMan BLV qPCR developed and validated by NVRI (acting as reference WOAH laboratory) and the one adapted from this original protocol to be used with SYBR Green dye, allowing a significant reduction in costs [ 11 ]. Another 3 laboratories also performed NVRI´s qPCR with slight modifications (i.e., Spain performed a multiplex assay for internal normalization). The remaining 6 labs introduced novel methodologies to the trial including one ddPCR (UY).
To compare different qPCR methods, a more comprehensive sample panel, accounting for a more geographical diversification was used in this trial. The amounts of BLV DNA in these samples were representative of the different BLV proviral loads found in field samples (from 1 to > 10,000 copies of BLV proviral DNA). Of note, 34% of reference samples had less than 100 copies of BLV DNA per 100 ng; samples were lyophilized to grant better preservation and reduced variability during distribution to participants around the globe.
The panel included a single negative control and two positive controls. Diagnostic sensitivity (DxSn) was estimated for each qPCR. Considering the 43 positive samples, the DxSn for the different qPCRs were: qPCR1 = 100%, qPCR2 = 82%, qPCR3 = 86%, qPCR4 = 84%, qPCR5 = 93%, ddPCR6 = 74%, qPCR7 = 93%, qPCR8 = 98%, qPCR9 = 98%, qPCR10 = 98% and qPCR11 = 95%. The most sensitive method was the qPCR1, and the method with the lowest sensitivity was the ddPCR6 method. Twenty-nine out of 44 samples were identified correctly by all qPCRs. The remaining 15 samples gave discordant results. The comparison of qualitative qPCR results among all raters revealed an overall observed agreement of 87%, indicating strong interrater reliability (Cohen´s kappa = 0.396) [ 54 , 55 ].
There are several factors that contribute to variability in qPCR results (i.e., number of copies of target input, sample acquisition, processing, storage and shipping, DNA purification, target selection, assay design, calibrator, data analysis, etc.). For that reason and as expected, the level of agreement among sister qPCRs (qPCR7, qPCR9-11) sharing similar protocols was higher compared to the rest of assays; this was also true for qPCR8 which targets the same region of BLV pol gene (shares same primers) but has a particular set-up to be used with SYBR Green chemistry. Oppositely, lower sensitivity and larger discrepancy against other tests was observed for the ddPCR6 and qPCR2-4.
Based on these observations we investigated which factors might have accounted for larger assessment variability amongst tests. In the first place, we observed that the use of different chemistries was not detrimental for the sensitivity and agreement among tests; similar DxSn and comparable level of agreement were obtained comparing TaqMan (qPCR7, 10, 11) vs SYBR Green (qPCR8) chemistries while targeting identical BLV sequence and using same standards. Also, when a multiplex qPCR (TaqMan) targeting the same BLV sequence and using the same standard was compared to previous ones, agreement was kept high, indicating that the lower sensitivity described for some multiplex qPCRs did not take place in this comparison. The use of an international calibrator and the efficiency estimation (standard curve) might inform variability associated with different chemistries. In contrast, another multiplex assay targeting another region of BLV pol (qPCR2) showed much lower sensitivity and agreement. As qPCR2 is performed as service by private company and oligonucleotide sequences were not available, we were not able to investigate in which proportion each of these two variables contributed to the lower performance of this assay, but we note the addition of 4 µl genomic DNA to this assay that would have an impact the DxSn. In this regard, there is substantial evidence showing that the variability of target sequence among strains from different geographical areas, might affect the sensitivity of BLV qPCRs. Previous studies comparing the pol , gag , tax and env genes reported that the pol gene was the most suitable region to target for diagnostic purposes, since it provided the most-sensitive assays [ 11 , 15 , 56 , 57 , 58 , 59 ]. This might be due in part to higher sequence conservation of pol among strains from different geographical areas. Supporting this observation, it is noticeable how JPN qPCR improved their performance in the current trial, by targeting pol in place of tax , as it did in the previous interlaboratory trial. Since it is a commercial test, we cannot exclude other factors contributing for the performance upgrade observed for this qPCR. In the current study, qPCR3 and ddPCR6 targeting LTR and env sequences, showed lower performances than other assays. Standardization of DNA input into each qPCR would have likely resulted in higher concordance in results. For instance, qPCR1 added 10 µl of genomic DNA per reaction and ddPCR6 added 1 µl of genomic DNA, impacting the resulting sensitivity differences.
Since the sensitivity of each assay and, consequently, the level of agreement among assays might also be influenced by the number of BLV DNA copies present in each sample [ 48 ], we compared the average number of BLV DNA copies between a group of genomic DNA samples that gave concordant results and a group that gave discordant results, and observed that samples that gave discordant results had significantly lower numbers of BLV DNA copies than samples that gave concordant results. Related to this point, the degradation of target DNA during lyophilization, shipment and resuspension, could have been more significant in low-copy compared to high-copy samples. Consequently, the degradation of target DNA in samples with low copies of BLV DNA might have accounted for the greater level of discrepancy within this subset of samples. The rational of adding a large proportion of such samples (34% samples with less than 100 BLV copies per 100 ng of total DNA) was to mimic what is frequently observed in surveillance programs (i.e., hyperacute infection, chronic asymptomatic infection, etc.).
Quantitative methods for the detection of BLV DNA copies are important for segregation programs based on animal level of BLV PVL, as well as for scientific research and the study of BLV dynamics. When the numbers of copies of BLV DNA detected by different assays were compared, in the present study, we observed that although the ability to quantify BLV DNA differed among qPCRs/ddPCR and there were statistically significant differences in the distribution of copy numbers among assays, a strong average correlation was found for the eleven qPCRs/ddPCR. In this regard, the lack of an international calibrator (standard curve) could be a major contributor to the increment of quantitative variation amongst laboratories. For that reason, plasmid pBLV1 containing pol 120 bp sequence was originally constructed for use as standard for quantification and shared with some collaborators (i.e., qPCR7, qPCR8, qPCR 9, qPCR10 and qPCR11). Remarkably, the laboratories used pBLV1 standard in the current trial obtained the most comparable results, indicating that the use of an international standard may have significant impact on the convergence of results; such standard reference material should be prepared under identical conditions. To avoid further variability a detailed protocol for lyophilized DNA sample resuspension, quantitation and template input into each qPCR should be shared with all participants.
BLV DNA was detected with different level of sensitivity in serologically positive samples from different origin and classified into different BLV genotypes. Overall agreement was high; however, we found significant differences in results for the samples with low BLV DNA copy numbers. This second interlaboratory study demonstrated that differences in target sequence, DNA input and calibration curve standards can increase interlaboratory variability considerably. Next steps should focus on (i) standard unification (international gold standard) to estimate individual test efficiency and improve quantitative accuracy amongst tests; (ii) building a new panel of samples with low BLV DNA copy numbers to re-evaluate sensitivity and quantitation of molecular methods. Since no variation was observed in samples from different genotypes, all samples will be collected in Poland to standardize the collection, purification, lyophilization and shipping steps with precise instructions for suspension and constant input volume for the PCR reaction. Finally, we believe that following this standardization approach we will be able to improve overall agreement amongst tests, improving the diagnostic of BLV around the world.
Not applicable.
No datasets were generated or analysed during the current study.
One-way analysis of variance
Bovine leukemia virus
BLV-specific antibodies
Digital PCR
Diagnostic sensitivity
Enzootic bovine leukosis
Enzyme-linked immunosorbent assays
Real-time fluorescence resonance energy transfer PCR
Genomic quality number
Histone H3 family 3A housekeeping gene
Maximum likelihood phylogenetic tree
Multiple-sequence alignment
Peripheral blood leukocytes
Phosphate-buffered saline
Proviral load
Quantitative real-time PCR
Room temperature
World Organisation for Animal Health
Coffin JM, Hughes SH, Varmus HE. (Eds.). 1650–1655 (1997). Retroviruses. Cold Spring Harbor Laboratory Press.
Ghysdael J, Bruck C, Kettmann R, Burny A. Bovine leukemia virus. Curr Top Microbiol Immunol. 1984;112:1–19.
CAS PubMed Google Scholar
Ott SL, Johnson R, Wells SJ. Association between bovine-leukosis virus seroprevalence and herd-level productivity on US dairy farms. Prev Vet Med. 2003;61:249–62.
Article CAS PubMed Google Scholar
Bartlett PC, et al. Options for the control of bovine leukemia virus in dairy cattle. J Am Vet Med Assoc. 2014;244:914–22.
Article PubMed Google Scholar
Kuczewski A, et al. Economic evaluation of 4 bovine leukemia virus control strategies for Alberta dairy farms. J Dairy Sci. 2019;102:2578–92.
Frie MC, Coussens PM. Bovine leukemia virus: a major silent threat to proper immune responses in cattle. Vet Immunol Immunopathol. 2015;163:103–14.
Panel, E.A. Scientific opinion on enzootic bovine leukosis. EFSA J. 2015;13:4188.
Google Scholar
OIE. World Animal Health Information Database - Version: 1.4. World Animal Health Information Database. Paris, France: World Organisation for Animal Health; 2009. Available from: http://www.oie.int . Accessed 16 Aug 2024.
Health, W.O.f.A. Manual of diagnostic tests and vaccines for terrestrial animals. Infect Bursal Dis. 2012;12:549–65.
Hutchinson HC, et al. Bovine leukemia virus detection and dynamics following experimental inoculation. Res Vet Sci. 2020;133:269–75.]
Rola-Luszczak M, Finnegan C, Olech M, Choudhury B, Kuzmak J. Development of an improved real time PCR for the detection of bovine leukaemia provirus nucleic acid and its use in the clarification of inconclusive serological test results. J Virol Methods. 2013;189:258–64.
Nakada S, Kohara J, Makita K. Estimation of circulating bovine leukemia virus levels using conventional blood cell counts. J Dairy Sci. 2018;101:11229–36.
Ruggiero VJ, Bartlett PC. Control of Bovine Leukemia Virus in Three US Dairy Herds by Culling ELISA-Positive Cows. Vet Med Int. 2019;2019:3202184.
Article PubMed PubMed Central Google Scholar
Kobayashi T, et al. Increasing Bovine leukemia virus (BLV) proviral load is a risk factor for progression of Enzootic bovine leucosis: A prospective study in Japan. Prev Vet Med. 2020;178: 104680.
Article Google Scholar
Jaworski JP, Pluta A, Rola-Łuszczak M, McGowan SL, Finnegan C, Heenemann K, Carignano HA, Alvarez I, Murakami K, Willems L, Vahlenkamp TW, Trono KG, Choudhury, B, Kuźmak J. Interlaboratory Comparison of Six Real-Time PCR Assays for Detection of Bovine Leukemia Virus Proviral DNA. J Clin Microbiol. 2018;56(7):e00304-18. https://doi.org/10.1128/JCM.00304-18 .
Pluta A, Rola-Luszczak M, Douville RN, Kuzmak J. Bovine leukemia virus long terminal repeat variability: identification of single nucleotide polymorphisms in regulatory sequences. Virol J. 2018;15:165.
Article CAS PubMed PubMed Central Google Scholar
Pluta A, Willems L, Douville RN, Kuźmak J. Effects of Naturally Occurring Mutations in Bovine Leukemia Virus 5'-LTR and Tax Gene on Viral Transcriptional Activity. Pathog. 2020;9(10):836. https://doi.org/10.3390/pathogens9100836 .
Pluta A, et al. Molecular characterization of bovine leukemia virus from Moldovan dairy cattle. Arch Virol. 2017;162:1563–76.
Rola-Łuszczak M, Sakhawat A, Pluta A, Ryło A, Bomba A, Bibi N, Kuźmak J. Molecular Characterization of the env Gene of Bovine Leukemia Virus in Cattle from Pakistan with NGS-Based Evidence of Virus Heterogeneity. Pathogens (Basel, Switzerland). 2021;10(7):910. https://doi.org/10.3390/pathogens10070910 .
Rola-Luszczak M, et al. The molecular characterization of bovine leukaemia virus isolates from Eastern Europe and Siberia and its impact on phylogeny. PLoS ONE. 2013;8: e58705.
Pinheiro de Oliveira TF, et al. Detection of contaminants in cell cultures, sera and trypsin. Biologicals. 2013;41:407–14.
Pluta A, Blazhko NV, Ngirande C, Joris T, Willems L, Kuźmak J. Analysis of Nucleotide Sequence of Tax, miRNA and LTR of Bovine Leukemia Virus in Cattle with Different Levels of Persistent Lymphocytosis in Russia. Pathogens. 2021;10(2):246. https://doi.org/10.3390/pathogens10020246 .
Yang Y, et al. Bovine leukemia virus infection in cattle of China: Association with reduced milk production and increased somatic cell score. J Dairy Sci. 2016;99:3688–97.
DeGraves FJ, Gao D, Kaltenboeck B. High-sensitivity quantitative PCR platform. Biotechniques. 2003;34(106–110):112–105.
Fonseca Junior AA, et al. Evaluation of three different genomic regions for detection of bovine leukemia virus by real-time PCR. Braz J Microbiol. 2021;52:2483–8.
Farias MVN, et al. Toll-like receptors, IFN-gamma and IL-12 expression in bovine leukemia virus-infected animals with low or high proviral load. Res Vet Sci. 2016;107:190–5.
Holland PM, Abramson RD, Watson R, Gelfand DH. Detection of specific polymerase chain reaction product by utilizing the 5’––3’ exonuclease activity of Thermus aquaticus DNA polymerase. Proc Natl Acad Sci U S A. 1991;88:7276–80.
De Brun ML, et al. Development of a droplet digital PCR assay for quantification of the proviral load of bovine leukemia virus. J Vet Diagn Invest. 2022;34:439–47.
Rola-Łuszczak M, Finnegan C, Olech M, Choudhury B, Kuźmak J. Development of an improved real time PCR for the detection of bovine leukaemia provirus nucleic acid and its use in the clarification of inconclusive serological test results. J Virol Methods. 2013;189:258–64.
Petersen MI, Alvarez I, Trono KG, Jaworski JP. Quantification of bovine leukemia virus proviral DNA using a low-cost real-time polymerase chain reaction. J Dairy Sci. 2018;101:6366–74.
Toussaint JF, Sailleau C, Breard E, Zientara S, De Clercq K. Bluetongue virus detection by two real-time RT-qPCRs targeting two different genomic segments. J Virol Methods. 2007;140:115–23.
John EE, et al. Development of a predictive model for bovine leukemia virus proviral load. J Vet Intern Med. 2022;36:1827–36.
Farias MVN, et al. Toll-like receptors, IFN-γ and IL-12 expression in bovine leukemia virus-infected animals with low or high proviral load. Res Vet Sci. 2016;107:190–5.
Yoneyama S, et al. Comparative Evaluation of Three Commercial Quantitative Real-Time PCRs Used in Japan for Bovine Leukemia Virus. Viruses. 2022;14:1182.
Polat M, Takeshima SN, Aida Y. Epidemiology and genetic diversity of bovine leukemia virus. Virol J. 2017;14:209.
Lee E, et al. Molecular epidemiological and serological studies of bovine leukemia virus (BLV) infection in Thailand cattle. Infect Genet Evol. 2016;41:245–54.
Duran-Yelken S, Alkan F. Molecular analysis of the env, LTR, and pX regions of bovine leukemia virus in dairy cattle of Türkiye. Virus Genes. 2024;60:173–85.
Lv G, Wang J, Lian S, Wang H, Wu R. The Global Epidemiology of Bovine Leukemia Virus: Current Trends and Future Implications. Animals. 2024;14(2):297. https://doi.org/10.3390/ani14020297 .
Úsuga-Monroy C, Díaz FJ, Echeverri-Zuluaga JJ, González-Herrera LG, López-Herrera A. Presence of bovine leukemia virus genotypes 1 and 3 in Antioquia, Colombia. Revista UDCA Actualidad & Divulgación Científica. 2018;21:119–26.
Úsuga-Monroy C, Díaz FJ, González-Herrera LG, Echeverry-Zuluaga JJ, López-Herrera A. Phylogenetic analysis of the partial sequences of the env and tax BLV genes reveals the presence of genotypes 1 and 3 in dairy herds of Antioquia. Colombia VirusDisease. 2023;34:483–97.
Martin D, et al. Comparative study of PCR as a direct assay and ELISA and AGID as indirect assays for the detection of bovine leukaemia virus. J Vet Med B Infect Dis Vet Public Health. 2001;48:97–106.
Cohen J. A Coefficient of Agreement for Nominal Scales. Educ Psychol Measur. 1960;20:37–46.
Feinstein AR, Cicchetti DV. High agreement but low kappa: I. The problems of two paradoxes. J Clin Epidemiol. 1990;43:543–9.
Woolhouse MEJ, et al. Heterogeneities in the transmission of infectious agents: Implications for the design of control programs. Proc Natl Acad Sci. 1997;94:338–42.
Ohshima K, Okada K, Numakunai S, Kayano H, Goto T. An eradication program without economic loss in a herd infected with bovine leukemia virus (BLV). Nihon Juigaku Zasshi. 1988;50:1074–8.
Juliarena MA, Gutierrez SE, Ceriani C. Determination of proviral load in bovine leukemia virus-infected cattle with and without lymphocytosis. Am J Vet Res. 2007;68:1220–5.
Mirsky ML, Olmstead CA, Da Y, Lewin HA. The prevalence of proviral bovine leukemia virus in peripheral blood mononuclear cells at two subclinical stages of infection. J Virol. 1996;70:2178–83.
Eaves FW, Molloy JB, Dimmock CK, Eaves LE. A field evaluation of the polymerase chain reaction procedure for the detection of bovine leukaemia virus proviral DNA in cattle. Vet Microbiol. 1994;39:313–21.
Juliarena MA, Barrios CN, Ceriani MC, Esteban EN. Hot topic: Bovine leukemia virus (BLV)-infected cows with low proviral load are not a source of infection for BLV-free cattle. J Dairy Sci. 2016;99:4586–9.
Yuan Y, et al. Detection of the BLV provirus from nasal secretion and saliva samples using BLV-CoCoMo-qPCR-2: Comparison with blood samples from the same cattle. Virus Res. 2015;210:248–54.
Taxis TM, et al. Reducing bovine leukemia virus prevalence on a large midwestern dairy farm by using lymphocyte counts, ELISA antibody testing, and proviral load. The Bovine Practitioner. 2020;54:136–44.
McHugh ML. Interrater reliability: the kappa statistic. Biochem Med (Zagreb). 2012;22:276–82.
Cicchetti DV, Feinstein AR. High agreement but low kappa: II. Resolving the paradoxes J Clin Epidemiol. 1990;43:551–8.
Heenemann K, et al. Development of a Bovine leukemia virus polymerase gene–based real-time polymerase chain reaction and comparison with an envelope gene–based assay. J Vet Diagn Invest. 2012;24:649–55.
Lew AE, et al. Sensitive and specific detection of proviral bovine leukemia virus by 5′ Taq nuclease PCR using a 3′ minor groove binder fluorogenic probe. J Virol Methods. 2004;115:167–75.
Takeshima SN, Sasaki S, Meripet P, Sugimoto Y, Aida Y. Single nucleotide polymorphisms in the bovine MHC region of Japanese Black cattle are associated with bovine leukemia virus proviral load. Retrovirology. 2017;14:24.
Debacq C, et al. Reduced proviral loads during primo-infection of sheep by Bovine Leukemia virus attenuated mutants. Retrovirology. 2004;1:31.
Kuckleburg CJ, et al. Detection of bovine leukemia virus in blood and milk by nested and real-time polymerase chain reactions. J Vet Diagn Invest. 2003;15:72–6.
Dube S, et al. Degenerate and specific PCR assays for the detection of bovine leukaemia virus and primate T cell leukaemia/lymphoma virus pol DNA and RNA: phylogenetic comparisons of amplified sequences from cattle and primates from around the world. J Gen Virol. 1997;78(Pt 6):1389–98.
Download references
The authors thank Luc Willems (University of Liège, Belgium) for plasmid DNA sample pBLV344; Marlena Smagacz and Eliza Czarnecka (National Veterinary Research Institute, Poland) for lyophilizing DNA samples and DNA analysis, respectively; Ali Sakhawat (Animal Quarantine Department, Pakistan), Vitaliy Bolotin (National Scientific Center IECVM, Ukraine), Frank van der Meer and Sulav Shrestha (University of Calgary, Canada) for sharing material.
The APC was funded by the National Veterinary Research Institute, Puławy, Poland.
Authors and affiliations.
Department of Biochemistry, National Veterinary Research Institute, Puławy, 24-100, Poland
Aneta Pluta & Jacek Kuźmak
Instituto de Virología E Innovaciones Tecnológicas (IVIT), Centro de Investigaciones en Ciencias Veterinarias y Agronómicas (CICVyA), Instituto Nacional de Tecnología Agropecuaria (INTA) - CONICET, Buenos Aires, Argentina
Juan Pablo Jaworski & Vanesa Ruiz
CentralStar Cooperative, 4200 Forest Rd, Lansing, MI, 48910, USA
Casey Droscha & Sophie VanderWeele
Department of Animal Science, College of Agriculture and Natural Resources, Michigan State University, East Lansing, Michigan, 48824, USA
Tasia M. Taxis
Niort Laboratory, Unit Pathology and Welfare of Ruminants, French Agency for Food, Environmental and Occupational Health and Safety (Anses), Ploufragan-Plouzané, Niort, France
Stephen Valas
Croatian Veterinary Institute, Savska Cesta 143, Zagreb, 10000, Croatia
Dragan Brnić & Andreja Jungić
Laboratorio Central de Veterinaria (LCV), Ministry of Agriculture, Fisheries and Food, Carretera M-106 (Km 1,4), Madrid, Algete, 28110, Spain
María José Ruano & Azucena Sánchez
Department of Veterinary Sciences, Faculty of Agriculture, Iwate University, 3-18-8 Ueda, Morioka, 020-8550, Japan
Kenji Murakami & Kurumi Nakamura
Departamento de Patobiología, Facultad de Veterinaria, Unidad de Microbiología, Universidad de La República, Ruta 8, Km 18, Montevideo, 13000, Uruguay
Rodrigo Puentes & MLaureana De Brun
Laboratorio de Virología, Departamento SAMP, Centro de Investigación Veterinaria de Tandil-CIVETAN (CONICET/UNCPBA/CICPBA), Buenos Aires, Argentina
Marla Eliana Ladera Gómez, Pamela Lendez & Guillermina Dolcini
Laboratório Federal de Defesa Agropecuária de Minas Gerais, Pedro Leopoldo, Brazil
Marcelo Fernandes Camargos & Antônio Fonseca
Department of Pathobiology, College of Veterinary Medicine, Auburn University, Auburn, AL, 36849-5519, USA
Subarna Barua & Chengming Wang
Department of Omics Analyses, National Veterinary Research Institute, 24-100, Puławy, Poland
Aneta Pluta & Aleksandra Giza
You can also search for this author in PubMed Google Scholar
Proposed the conception and design of the study, A.P.; data curation, A.P., J.P.J., C.D., S.V., D.B., A.S., K.M., R.P., G.D., M.F.C. and CH.W.; investigation, A.P., V.R., S.VW., S.V., A.J., M.J.R., K.N., M.L.B., M.L.G., P.L., A.F., A.G. and S.B., formal analysis, A.P.; statistical analysis, A.P.; database analysis, A.P., visualization of the results, A.P.; resources, A.P., T.M.T. and J.K; writing—original draft preparation, A.P., J.P.J.; writing—review and editing, A.P., J.P.J., C.D., S.VW., T.M.T. and J.K; project administration, A.P. All authors read and approved the submitted version.
Correspondence to Aneta Pluta .
Ethics approval and consent to participate.
The study was approved by the Veterinary Sciences Animal Care Committee No. AC21-0210, Canada; the Institutional Animal Care and Use Committee No. PROTO202000096 from 4/13/2020 to 4/14/2023, Michigan State University, United States and the Ethics Review Board, COMSATS Institute of Information Technology, Islamabad, Pakistan, no. CIIT/Bio/ERB/17/26. Blood samples from Polish, Moldovan and Ukrainian cattle, naturally infected with BLV, were selected from collections at local diagnostic laboratories as part of the Enzootic bovine leukosis (EBL) monitoring program between 2012 and 2018 and sent to the National Veterinary Research Institute (NVRI) in Pulawy for confirmation study. The approval for collection of these samples from ethics committee was not required according to Polish regulation (“Act on the Protection of Animals Used for Scientific or Educational Purposes”, Journal of Laws of 2015). All methods were carried out in accordance with relevant guidelines and regulations. The owners of the cattle herds from which the DNA samples originated, the district veterinarians caring for these farms and the ministries of agriculture were informed and consented to the collection of blood from the animals for scientific purposes and the sending of samples to NVRI.
Competing interests.
The authors declare no competing interests.
Publisher’s note.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
12917_2024_4228_moesm1_esm.pdf.
Additional file 1. Copy of the instruction included with the panel of 44 DNA samples sent to participating laboratories for dilution of the lyophilisates
Additional file 2. Detection of the H3F3A gene copy number in 43 DNA samples; no outlier was found for any samples ( P <0.05) (two-sided).
Additional file 3. Concentration values of 44 DNA samples measured by the 11 participating laboratories (given in ng per µl)
Additional file 4. Post hoc - Dunn-Bonferroni-Tests. The Dunn-Bonferroni test revealed that the pairwise group comparisons of qPCR2 - qPCR4, qPCR3 - ddPCR6, qPCR4 - qPCR5, qPCR4 - ddPCR6, qPCR4 - qPCR9, qPCR4 - qPCR10, qPCR5 - qPCR11, ddPCR6 - qPCR11 and qPCR9 - qPCR11 have an adjusted p-value less than 0,05
Additional file 5. Kendall's Tau correlation coefficient values measured between each pair of assays. The numbers 1 to 11 in the first column and last row of the table indicate the names of the assays qPCR1-qPCR5, ddPCR6, qPCR7-qPCR11 respectively
Additional file 6. Maximum-likelihood phylogenetic analysis of full-length BLV-pol gene sequences representing 7 BLV genotypes (G1, G2, G3, G4, G6, G9, and G10) (A); (B) env-based sequences assigned to 10 BLV genotypes (G1, G2, G3, G4, G5, G6, G7, G8, G9, and G10); (C) LTR-based sequences representing 10 BLV genotypes (G1-G10). For all genes and LTR region the Tamura-Nei model and Bootstrap replications (1,000) were applied in MEGA X
Additional file 7. Multiple sequence alignment of reverse transcriptase, integrase, envelope and LTR sequences in the context of the specific primers used by different qPCR assays. (A) Multiple sequence alignment of reverse transcriptase (pol gene) sequences in the context of qPCR7, qPCR8, qPCR9, qPCR10 and qPCR11 assay primers. (B) Multiple sequence alignment of integrase (pol gene) sequences in the context of qPCR4 assay primers. (C) Multiple sequence alignment of env gene sequences in the context of ddPCR6. (D) Sequence alignment of LTR region sequences in the context of qPCR3 method primers
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ .
Reprints and permissions
Cite this article.
Pluta, A., Jaworski, J.P., Droscha, C. et al. Inter-laboratory comparison of eleven quantitative or digital PCR assays for detection of proviral bovine leukemia virus in blood samples. BMC Vet Res 20 , 381 (2024). https://doi.org/10.1186/s12917-024-04228-z
Download citation
Received : 24 November 2023
Accepted : 09 August 2024
Published : 26 August 2024
DOI : https://doi.org/10.1186/s12917-024-04228-z
Anyone you share the following link with will be able to read this content:
Sorry, a shareable link is not currently available for this article.
Provided by the Springer Nature SharedIt content-sharing initiative
ISSN: 1746-6148
IMAGES
COMMENTS
Unlike research questions in quantitative research, research questions in qualitative research are usually continuously reviewed and reformulated. The central question and associated subquestions are stated more than the hypotheses.15 The central question broadly explores a complex set of factors surrounding the central phenomenon, ...
Revised on June 22, 2023. Quantitative research is the process of collecting and analyzing numerical data. It can be used to find patterns and averages, make predictions, test causal relationships, and generalize results to wider populations. Quantitative research is the opposite of qualitative research, which involves collecting and analyzing ...
Abstract. In an era of data-driven decision-making, a comprehensive understanding of quantitative research is indispensable. Current guides often provide fragmented insights, failing to offer a holistic view, while more comprehensive sources remain lengthy and less accessible, hindered by physical and proprietary barriers.
Qualitative research is a method to explore and understand the meaning of individuals or groups regarding social or human problems ( Creswell, 2003 ), it" engage in naturalistic inquiry, studying real-world settings inductively to generate rich narrative descriptions and construct case studies.". ( Patton, 2005 ).
Quantitative research is the process of collecting and analyzing numerical data to describe, predict, or control variables of interest. This type of research helps in testing the causal relationships between variables, making predictions, and generalizing results to wider populations. The purpose of quantitative research is to test a predefined ...
Quantitative research explains phenomena by collecting numerical unchanging d etailed data t hat. are analyzed using mathematically based methods, in particular statistics that pose questions of ...
quantitative research are: Describing a problem statement by presenting the need for an explanation of a variable's relationship. Offering literature, a significant function by answering research ...
What is Quantitative Research? Quantitative methodology is the dominant research framework in the social sciences. It refers to a set of strategies, techniques and assumptions used to study psychological, social and economic processes through the exploration of numeric patterns.Quantitative research gathers a range of numeric data.
Revised on 10 October 2022. Quantitative research is the process of collecting and analysing numerical data. It can be used to find patterns and averages, make predictions, test causal relationships, and generalise results to wider populations. Quantitative research is the opposite of qualitative research, which involves collecting and ...
Quantitative research, according to Apuke (2017), is "one that works with quantifying and analyzing variables to produce results". It includes the analysis of data using numerical and statistical ...
This article describes the basic tenets of quantitative research. The concepts of dependent and independent variables are addressed and the concept of measurement and its associated issues, such as error, reliability and validity, are explored. Experiments and surveys - the principal research designs in quantitative research - are described ...
Quantitative Research. Quantitative research is a type of research that collects and analyzes numerical data to test hypotheses and answer research questions.This research typically involves a large sample size and uses statistical analysis to make inferences about a population based on the data collected.
Quantitative Research Methodologies. Correlational; Researchers will compare two sets of numbers to try and identify a relationship (if any) between two things. Descriptive; Researchers will attempt to quantify a variety of factors at play as they study a particular type of phenomenon or action. For example, researchers might use a descriptive ...
Quantitative research enhances research projects. Quantitative research approaches are so much more than "how much" or "how many," they reveal the why behind people's actions, emotions and behaviors. By using standardized collection methods, like surveys, quant instills confidence and rigor in findings. Quantitative research has many ...
Quantitative research is the methodology which researchers use to test theories about people's attitudes and behaviors based on numerical and statistical evidence. Researchers sample a large number of users (e.g., through surveys) to indirectly obtain measurable, bias-free data about users in relevant situations.
Tips for Finding Quantitative Articles with a Keyword Search. If you want to limit your search to quantitative studies, first try "quantitative" as a keyword, then try using one of the following terms/phrases in your search (example: lactation AND statistics): Correlational design*. Effect size. Empirical research. Experiment*.
Quantitative Research for the Qualitative Researcher. 2014. SAGE Knowledge. Book chapter . Issues in Validity and Reliability. Show details Hide details. Daniel J. Boudah. Conducting Educational Research: Guide to Completing a Major Project. 2011. SAGE Knowledge. Entry . Quantitative Research.
The main difference between quantitative and qualitative research is the type of data they collect and analyze. Quantitative research collects numerical data and analyzes it using statistical methods. The aim is to produce objective, empirical data that can be measured and expressed numerically. Quantitative research is often used to test ...
Quantitative research Quantitative research is expressed in numbers and graphs. It is used to test or confirm theories and assumptions. This type of research can be used to establish generalizable facts. about a topic. Common quantitative methods include experiments, observations recorded as numbers, and surveys with closed-ended questions. ...
When conducting quantitative research, scientific researchers should describe an existing theory, generate a hypothesis from the theory, test their hypothesis in novel research, and re-evaluate the theory. Thereafter, they should take a deductive approach in writing the testing of the established theory based on experiments.
To locate qualitative research articles, use a subject-specific database or a general library database like Academic Search Ultimate or Google Scholar. Finding this types of research takes a bit of investigation. Try this method. Begin by entering your keywords and conducting a search. Since quantitative research is based on the collection and ...
Whereas quantitative research uses variable-based models that abstract from individual cases, qualitative research favors case-based models that abstract from individual characteristics. Variable-based models are usually stated in the form of quantified sentences (scientific laws). This syntactic structure implies that sentences about ...
Multidimensional analysis of the linguistic phenomena improves the analytic potential. This article focuses on the application of quantitative methods in schoolscape research, including a discussion of its advantages and disadvantages. This article seeks to rehabilitate the quantitative by re-theorizing the landscape in linguistic landscape (LL ...
In this article, we explore what quantitative data analysis is, the difference between quantitative and qualitative data analysis, and statistical methods you can apply to your data. ... When conducting quantitative research, you don't have room to improvise based on the findings. You need to have predefined hypotheses, follow scientific ...
Quantitative research methods. Quantitative data collection methods are more diverse and more likely to be automated because of the objective nature of the data. A quantitative researcher could employ methods such as: Surveys with close-ended questions that gather numerical data like birthdates or preferences;
General Instructions (1) Read the two research articles provided to you in the week 3 reading section. One article will be a qualitative research example and the other will be a quantitative research example. (2) Write a critique on one of the articles. Use the template below for your submission. Five sections have been identified.
STT: Mixed methods research can strengthen quantitative research and clinical studies in a few ways. First, this approach enriches diversity in practice, data, and applications. Second, it can reduce biases introduced by big data or AI. Some examples include (1) capturing the social, cultural, and psychological complexities of individual ...
Introduction. Recognition has grown that while quantitative methods remain vital, they are usually insufficient to address complex health systems related research questions. 1 Quantitative methods rely on an ability to anticipate what must be measured in advance. Introducing change into a complex health system gives rise to emergent reactions, which cannot be fully predicted in advance.
She has extensive experience in curriculum design and English language teaching. She has published many journal articles and was PI for multiple research projects. She is also serving as a reviewer for multiple international journals. Her primary research areas are business English, curriculum design, academic advising, and classroom management.
Bovine leukemia virus (BLV) is the etiological agent of enzootic bovine leukosis and causes a persistent infection that can leave cattle with no symptoms. Many countries have been able to successfully eradicate BLV through improved detection and management methods. However, with the increasing novel molecular detection methods there have been few efforts to standardize these results at global ...